Home | People | Publications | Contact
PDBcal: A Comprehensive Dataset for Receptor-Ligand Interactions with Three-Dimensional structures and Binding Thermodynamics from Isothermal Titration Calorimetry

L. Li, J. J. Dantzer, J. Nowacki, B. J. O'Callaghan and S. O. Meroueh "PDBcal: A Comprehensive Dataset for Receptor-Ligand Interactions with Three-Dimensional Structures and Binding Thermodynamics from Isothermal Titration Calorimetry" Chem. Biol. & Drug Design. (2008) 71:529-32.


Please assist us in our effort and deposit your data.  

General Info Receptor Ligand PDB
(complex)		 PDB
(receptor)		 ΔG
(kcal/mol)		 ΔH
(kcal/mol)		 TΔS
(kcal/mol)		 ΔCp
(cal/molT)		 Reference
222 16S-rRNA A-site paromomycin 1J7T   -10.3±0.2 -2.8±0.1 7.5±0.3 2005
223 16S-rRNA A-site G418 (geneti 1MWL   -7.5±0.2 -1.7±0.1 5.8±0.3 2005
451 6D9 antibody transition-s 2DQU   -13.46 -9.31±0.05 4.15 -420 2007
19 AAC(6p)-Iy ribostamycin 1S3Z 1B87 -8.3±0.083 -19.9±0.8 -11.6±0.81 2002
20 AAC(6p)-Iy kanamycin B   1B87 -7±0.07 -13±0.52 -6±0.42 2002
21 AAC(6p)-Iy tobramycin   1B87 -7.3±0.07 -12.1±0.48 -4.8±0.34 2002
22 AAC(6p)-Iy dibekacin   1B87 -7.4±0.07 -12.8±0.51 -5.4±0.38 2002
23 AAC(6p)-Iy gentamicin C   1B87 -6.4±0.06 -8.1±0.32 -1.7±0.12 2002
24 AAC(6p)-Iy kanamycin A   1B87 -6.6±0.07 -9.6±0.38 -3.3±0.23 2002
25 AAC(6p)-Iy amikacin   1B87 -6.6±0.07 -5.7±0.23 0.9±0.06 2002
26 AAC(6p)-Iy sisomicin   1B87 -7.2±0.07 -8.9±0.36 -1.7±0.12 2002
27 AAC(6p)-Iy netilmicin   1B87 -7.3±0.07 -6±0.24 1.3±0.09 2002
28 AAC(6p)-Iy butirosin   1B87 -8.1±0.08 -12.6±0.5 -4.5±0.32 2002
29 AAC(6p)-Iy neomycin B   1B87 -7.5±0.08 -14.7±0.59 -7.2±0.5 2002
30 AAC(6p)-Iy paromomycin   1B87 -6.8±0.07 -7.5±0.3 -0.7±0.05 2002
31 AAC(6p)-Iy lividomycin   1B87 -7.3±0.07 -9.4±0.38 -2.1±0.15 2002
32 AAC(6p)-Iy+CoA lividomycin   1B87 -8.5±0.09 -10.6±0.42 -2.1±0.15 2002
283 Ab 3B44 (anti-NP 4-hydroxy-3- 1YUH   -11.8±0.1 -16.5±0.2 -4.69±0.27 -363 1995
295 Abl-SH3 domain p40 decapept   1ABQ -7.7 -21.1 -13.4 2004
294 Abl-SH3 domain p41 decapept 1BBZ 1ABQ -7.7 -21.9 -14.2 -174 2004
296 Abl-SH3 domain p7 decapepti   1ABQ -7.6 -18.3 -10.7 2004
297 Abl-SH3 domain p17 decapept   1ABQ -6.9 -17.5 -10.6 2004
298 Abl-SH3 domain p0 decapepti   1ABQ -6.9 -17 -10.1 2004
299 Abl-SH3 domain 3BP1 decapep   1ABQ -6.1 -16.7 -10.6 2004
213 acteylhexosaminy UDP-GalNAc 1OMZ 1OMX -5.84±0.07 -2.1±0.07 3.74 2005
214 acteylhexosaminy UDP-GlcNAc 1ON6 1OMX -5.84±0.07 -1.98±0.07 3.87 2005
434 Aldose reductase lead 1 2IKG   -8.46 -6.11±0.29 2.34 2007
435 Aldose reductase lead 2 2IKH   -7.48 -2.08±0.24 5.4 2007
436 Aldose reductase lead 3 2IKI   -10.2 -14.83±0.33 -4.63 2007
437 Aldose reductase lead 4 2IKJ   -10.08 -18.89±0.29 -8.81 2007
262 Aminoglycoside-3 kanamycin A   1J7I -7.4 -33 -25.6 2004
263 Aminoglycoside-3 kanamycin B   1J7I -9.2 -22.4 -13.2 2004
264 Aminoglycoside-3 tobramycin   1J7I -8.7 -29.2 -20.5 2004
265 Aminoglycoside-3 amikacin   1J7I -5.7 -19.5 -13.8 2004
266 Aminoglycoside-3 ribostamycin   1J7I -8.1 -30.1 -22 2004
267 Aminoglycoside-3 neomycin B   1J7I -9.3 -33.4 -24.1 2004
268 Aminoglycoside-3 paromomycin   1J7I -9 -30.4 -21.4 2004
269 Aminoglycoside-3 lividomycin   1J7I -8.6 -33.6 -25 2004
284 apocytochrome b5 heme   1YYJ -11±0.2 -17±1 -5.69 381 1997
145 B-FABP docosahexaen 1FDQ 1JJX -10.1 -12.71±1.15 -2.6±1.15 2000
300 B-FABP lauric acid   1JJX -8.81±0.07 -8.91±0.43 -0.1±0.53 2000
301 B-FABP palmitoleic   1JJX -10.23±0.02 -10.32±0.55 0.07±0.53 2000
302 B-FABP oleic acid   1JJX -10.16±0.02 -11.63±0.72 -1.46±0.69 2000
303 B-FABP linoleic aci   1JJX -9.62±0.09 -12.21±1.39 -2.58±1.36 2000
304 B-FABP arachidonic   1JJX -9.27±0.05 -14.4±1.58 -5.16±1.58 2000
305 B-FABP alpha-linole   1JJX -10.48±0.03 -14.43±1.43 -3.94±1.39 2000
306 B-FABP eicosapentae   1JJX -10.14±0.22 -12.47±0.57 -2.27±0.79 2000
410 beta-Lg A (bovin peptide-site   1CJ5 -4.55 -5.95±1.9 -1.4 2006
276 beta-Lg A (bovin peptide-site   1CJ5 -4.02 -4.47±3.95 -0.45 2006
277 beta-Lg A (bovin peptide-site   1CJ5 -3.5 29.44±3.63 32.8 2006
46 BirA biotin 1HXD 1BIA -9.9 -9.4 0.5 -190 2002
47 BirA biotin-5p-AM 2EWN 1BIA -14 -5.8 8.1 -200 2002
103 bovine carbonic ArEG1OMe   1V9E -9.84±-0.09 -10.2±0.5 0.5±0.5 -40 2006
102 bovine carbonic p-H2NSO2C6H4   1V9E -8.59±0.02 -14.8±0.4 -6.26±0.5 2006
101 bovine carbonic p-H2NSO2C6H4   1V9E -9.13±0.1 -10.8±0.4 -1.64±0.5 2006
105 bovine carbonic ArEG2OMe   1V9E -9.64±0.07 -10±0.3 -0.4±0.3 2006
106 bovine carbonic ArEG3OMe   1V9E -9.54±0.06 -10±0.3 -0.4±0.3 2006
107 bovine carbonic ArEG4OMe   1V9E -9.44±0.05 -9.4±0.3 0.03±0.3 2006
108 bovine carbonic ArEG5OMe   1V9E -9.39±0.04 -9±0.3 0.4±0.3 -40 2006
109 bovine carbonic ArGlyO-   1V9E -8.98±0.02 -13.3±0.4 -4.3±0.4 -24 2006
110 bovine carbonic ArGly2O-   1V9E -9.13±0.03 -12.9±0.4 -3.8±0.4 2006
111 bovine carbonic ArGly3O-   1V9E -9.05±0.03 -12.3±0.4 -3.2±0.4 -18 2006
112 bovine carbonic ArGly4O-   1V9E -9±0.02 -11.1±0.5 -2.2±0.5 -20 2006
113 bovine carbonic ArGly5O-   1V9E -8.91±0.02 -11.1±0.5 -2.2±0.5 -20 2006
115 bovine carbonic ArSar1O-   1V9E -8.46±0.02 -11.7±0.4 -3.2±0.4 -43 2006
116 bovine carbonic ArSar2O-   1V9E -8.89±0.02 -11.5±0.4 -2.6±0.4 2006
117 bovine carbonic ArSar3O-   1V9E -8.81±0.02 -10.4±0.4 -1.62±0.4 -45 2006
118 bovine carbonic ArSar4O-   1V9E -8.71±0.03 -10±0.4 -1.3±0.4 2006
119 bovine carbonic ArSar5O-   1V9E -8.65±0.03 -9.5±0.3 -0.9±0.3 -49 2006
232 bovine spleen ga disaccharide 1SLT   -5.47±0.45 -7.76±1.29 -2.29±1.36 1998
82 bovine trypsin N(alpha)-(2- 1K1I 1N6X -8.69 -10.89±0.12 -2.2±0.12 -619 2001
84 bovine trypsin N(alpha)-(2- 1K1J 1N6X -10.41 -9.46±0.24 0.96±0.26 -621 2001
85 bovine trypsin N(alpha)-(2- 1K1L 1N6X -9.74 -7.86±0.24 1.89±0.31 -525 2001
86 bovine trypsin N(alpha)-(2- 1K1M 1N6X -10.2 -8.22±0.19 1.96±0.21 -611 2001
87 bovine trypsin CRC220 1K1N 1N6X -9.15 -5.9±0.29 2.53±0.29 -287 2001
319 bovine trypsin phenylalanin   1N6X -10.15 -6.47±0.26 3.68±0.31 2001
320 bovine trypsin phenylalanin   1N6X -8.84 -4.04±0.19 4.92±0.29 -666 2001
321 bovine trypsin phenylalanin   1N6X -8.48 -6.4±0.19 2.08±0.21 -540 2001
322 bovine trypsin Napsagatran   1N6X -7.64 -7.52±0.21 0.12±0.24 -217 2001
176 BtkPH domain Ins(1,3,4,5) 1B55   -9.8 6.7±0.1 16.5 1999
177 BtkPH domain mut Ins(1,3,4,5) 1BWN   -9.33 6.4±0.1 15.7 1999
246 CAP cAMP-1 1G6N   -10.3 -1.8 8.5 2006
247 CAP cAMP-2 1G6N   -7.5 -2.9 4.6 2006
310 cardiac calseque amitriptylin   1SJI -6.58 -9.8 -3.25 2005
309 cardiac calseque doxorubicin   1SJI -6 -3.7 2.3 2005
226 cardiac calseque promethazine   1SJI -6.58 -12.5 -5.87 2005
227 cardiac calseque chlorpromazi   1SJI -6.16 -11.7 -5.54 2005
307 cardiac calseque trifluoperaz   1SJI -6.62 -14.6 -7.96 2005
308 cardiac calseque daunorubicin   1SJI -6.25 -4.3 1.94 2005
311 cardiac calseque nortriptylin   1SJI -6.76 -2.8 3.94 2005
74 CB41 (anti-p24 ( h-pep 1BOG 1CFQ -10.5 -13.9 -3.4 -257 2003
75 CB41 (anti-p24 ( d-pep 1CFT 1CFQ -7.7 -12.3 -4.6 2003
76 CB41 (anti-p24 ( e-pep 1CFN 1CFQ -10.4 -15.6 -5.2 -286 2003
77 CB41 (anti-p24 ( u-pep 1CFS 1CFQ -9.9 -15.3 -5.4 -233 2003
312 CB41 (anti-p24 ( GA-pep   1CFQ -9.9 -11.4 -1.5 2003
313 CB41 (anti-p24 ( AT-pep   1CFQ -9.3 -11.1 -1.8 2003
314 CB41 (anti-p24 ( SE-pep   1CFQ -7 -17.5 -10.4 2003
231 CHORISMATE MUTAS Transition S 1ECM   -7.6 -3.2±0.1 4.4 -88 1998
197 concanavalin A pyranoside 1 1GIC 1GKB -5.5±0.1 -4.5±0.03 -0.11±0.2 2005
317 concanavalin A septanosides   1GKB -3.6±0.3 -2.7±0.2 0.95±0.3 2005
316 concanavalin A pyranoside 2   1GKB -4.5±0.03 -3.5±0.9 0.98±0.2 2005
318 concanavalin A septanosides   1GKB -3.6±0.3 -2.4±0.8 1.2±1.1 2005
271 concanavalin A d methyl alpha   1GKB -5.3 -7.9 -2.6 2006
273 concanavalin A d ANS (site1)   1GKB -7.2±0.13 0.04±0.02 7.16±0.12 2006
274 concanavalin A d ANS (site2)   1GKB -4.98±0.09 -1.95±0.15 2.98±0.09 2006
95 CRP mutant (pH5. cAMP 1HW5   -4.44±0.07 1.15±0.1 5.54±0.14 2001
96 CRP mutant (pH7. cAMP 1HW5   -6.78±0.12 -0.98±0.14 5.82±0.85 2001
45 DNA gyrase novobiocin 1AJ6   -8.1±0.1 -17.5±0.1 -9.4±0.1 -454 1997
211 DNA(CGCGAATTCGCG Hoechst 3325 1D46   -11.8±0.1 10±0.1 21.8±0.1 2005
104 DPPA GlyLeu 1DPP 1DPE -8.08 -10.41 -2.33 2000
127 DPPA AlaThr   1DPE -10.61 -12.75 -2.14 2000
126 DPPA AlaVal   1DPE -10.52 -9.88 0.64 2000
128 DPPA LysAla   1DPE -10.4 -11.74 -1.34 2000
129 DPPA AlaAla   1DPE -10.38 -13.42 -3.04 2000
130 DPPA AlaSer   1DPE -10.36 -12.58 -2.22 2000
131 DPPA AlaLys   1DPE -10.31 -10.78 -0.47 2000
132 DPPA AlaLeu   1DPE -10.22 -7.63 2.59 2000
133 DPPA AlaIle   1DPE -9.87 -8.91 0.96 2000
136 DPPA SerAla   1DPE -9.82 -12.88 -3.06 2000
135 DPPA AlaPhe   1DPE -9.82 -12.22 -2.4 2000
137 DPPA ThrSer   1DPE -9.67 -18.07 -8.4 2000
138 DPPA AlaTyr   1DPE -9.23 -12.37 -3.14 2000
139 DPPA AlaPro   1DPE -9.23 -8.91 0.32 2000
140 DPPA AlaTrp   1DPE -9.01 -11.08 -2.07 2000
141 DPPA AlaAsp   1DPE -8.1 -8.35 -0.25 2000
142 DPPA GlyTyr   1DPE -7.57 -8.48 -0.91 2000
143 DPPA LeuTrp   1DPE -7.32 -12.69 -5.37 2000
144 DPPA AspAla   1DPE -7.11 -10.32 -3.21 2000
241 ECorL (Erythrina GalNAc 1AX0 1AXY -4.28±0.05 -5.49±0.38 -1.22±0.38 1996
242 ECorL (Erythrina Lac 1AX1 1AXY -4.49±0.02 -9.84±0.6 -5.37±0.6 1996
243 ECorL (Erythrina LacNAc 1AX2 1AXY -5.42±0.02 -11.25±0.62 -5.93±0.68 1996
325 ECorL (Erythrina 2p-FL   1AXY -4.85±0.02 -4.3±0.21 0.55±0.09 1996
326 ECorL (Erythrina Gal   1AXY -4.35±0.05 -3.27±0.24 1.09±0.24 1996
327 ECorL (Erythrina Me-alpha-Gal   1AXY -4.32±0.05 -5.16±0.36 -0.85±0.36 1996
328 ECorL (Erythrina Me-beta-Gal   1AXY -3.89±0.05 -4.35±0.31 -0.47±0.31 1996
329 ECorL (Erythrina Me-alpha-DNS   1AXY -7.57±0.31 -5.52±0.17 2.14±0.06 1996
330 ECorL (Erythrina D-Fucose   1AXY -3.63±0.48 -1.12±0.1 2.51±0.28 1996
179 EcWT paromomycin 1PBR 1A3M -8.6±0.2 -3.1±0.1 5.5 2004
180 EcWT A1408G muta paromomycin 1FYP 1FYO -8.3±0.1 1.1±0.1 9.4 2004
44 EphB4 NYLF-RAW 2BBA   -9.8±0.1 -15.5±0.1 -5.7±0.1 2006
244 EPSP synthase S3P 1G6T 1EPS -6.86±0.04 -5.2±0.1 1.62±0.18 1996
331 EPSP synthase inhibitor 4   1EPS -8.61±0.04 -2.9±0.1 5.73±0.12 1996
332 EPSP synthase inhibitor 13   1EPS -6.34±0.17 -1.4±0.01 4.92±0.24 1996
333 EPSP synthase PEP   1EPS -4.68±0.02 -4.9±0.3 -0.18±0.24 1996
334 EPSP synthase glyphosate   1EPS -2.64±0.1 -13.7±1.6 -11±1.65 1996
245 EPSP synthase, S glyphosate 1G6S 1G6T -9.37±0.11 -19±0.4 -9.57±0.54 1996
80 Fab tAb2 e-pep (VVSHF 1E4X   -10.3 -24.8 -14.5 2001
81 Fab tAb2 hc-pep2 (cyd 1E4W   -10.3 -26.7 -16.4 2001
285 FabI 2-(2-hyroxyp   1DFI -9.31 -20.48±0.48 -10.94 -880 2004
286 FabI 5-methyl-2-(   1DFI -10.94 -19.39±0.29 -8.46 -800 2004
287 FabI 5-ethyl-2-(2   1DFI -12 -17.48±0.29 -5.51 -1200 2004
288 FabI 5-propyl-2-(   1DFI -11.7 -16.41±0.19 -4.73 -1280 2004
228 FadR myristoyl-Co 1H9G 1E2X -9.72±0.45 -20.66±1.86 -10.92±1.93 1998
335 FadR palmitoyl-Co   1E2X -8.96±0.43 -16.67±2.6 -7.74±2.7 1998
336 FadR oleoyl-CoA   1E2X -9.89±0.05 -19.73±0.67 -9.84±0.72 1998
251 FRP (flavin redu FMN (oxidize 1BKJ   -9.3 -21.5±0.4 -12.2 -1670 2006
79 glycohydrolitic chitotriose 1LZB 1LZA -7±0.01 -14.1±0.06 -7.1 -119 2003
337 glycohydrolitic chitobiose   1LZA -4.99 -11.22±0.04 -6.23 -83 2003
72 Glycyl-tRNA Synt adenosine 5p 1B76 1ATI -7.31±0.33 -17.2±2.05 -8.81±1 2003
233 Grb2-SH2 pY317 (Ac-Sp 1JYR 1JYU -9.12±0.02 -7.94±0.15 1.18±0.15 -146 1997
338 Grb2-SH2 Ac-ApYVNVQ-N   1JYU -8.95±0.13 -7.19±0.37 1.75±0.5 1997
339 Grb2-SH2 Ac-SpYANVQ-N   1JYU -7.73±0.05 -8.54±0.01 -0.81±0.06 1997
340 Grb2-SH2 Ac-SpYVAVQ-N   1JYU -4.62±0.08 -1.95±0.02 2.67±0.07 1997
341 Grb2-SH2 Ac-SpYVNAQ-N   1JYU -8.17±0.08 -5.97±0.19 2.21±0.27 1997
342 Grb2-SH2 Ac-SpYVNVA-N   1JYU -8.72±0.11 -7.14±0.56 1.58±0.67 1997
215 Grb7-SH2 PY1139 1MW4   -7.7±0.04 -4.66±0.05 3.04±0.09 2005
444 griffithsin mannose 2GUD 2GTY -5.53±0.08 -0.081±0.002 5.45±0.08 2007
445 griffithsin maltose 2HYR 2GTY -4.72±0.26 -0.048±0.005 4.67±0.26 2007
446 griffithsin 6alpha-manno 2HYQ 2GTY -5.65±0.12 -0.072±0.002 5.58±0.12 2007
270 Guanine Riboswit 2,6-diaminop 2B57   -10.73 -40.3±2.91 -29.59±1.21 2006
234 Gyrase B Fragmen Clorobiocin 1KZN   -9.785 -8.79±0.43 0.995 1997
73 hCyp18 (human cy CsA (cyclosp 1CWA 1OCA -10.9±0.03 -14.7±0.03 -3.8 -435.8 2003
55 hemophore HasAsm heme 1DKH 1YBJ -14.59±0.19 -25.17±0.91 -10.58±0.93 2003
272 hGST P1-1 GNSO 2A2R 16GS -11.6±0.1 -29.9±2.3 -18.3±2.3 2006
51 hGST P1-1 (human S-hexylGSH ( 9GSS 16GS -8.04±0.02 -16.13±0.07 -8.04±0.07 -441.6 2003
52 hGST P1-1 (human GSH(glutathi 6GSS 16GS -5.53±0.02 -11.21±0.12 -5.65±0.12 -294.2 2003
50 hGST P1-1 Y49F m GSH (glutath   22GS -4.88±0.01 -13.04±0.14 -9.17±0.14 -199.5 2003
53 hGST P1-1 Y49F m S-hexylGSH (   22GS -7.66±0.02 -17.14±0.08 -9.45±0.08 -333.6 2003
92 HIV-1 gp41 D10-p1 1CZQ 1AIK -6.88±0.01 -16.55±0.08 -9.69±0.09 2001
7 HIV-1 protease TMC-126   1HHP -15.6 -12 3.6 -350 2002
8 HIV-1 protease amprenavir   1HHP -13.2 -6.9 6.3 -440 2002
291 HIV-1 protease KNI-764   1HHP -14.9 -8 6.9 2002
290 HIV-1 protease KNI-272 1HPX 1HHP -13.3 -5.4 7.9 2003
181 HIV-1 protease TMC114 1T3R   -15.2 -12.1 3.1 2004
182 HIV-1 protease APV 1HPV 1HHP -12.6 -7.3 5.3 2004
203 HIV-1 protease atazanavir 2AQU 1HHP -15 -4.6 10.4 2005
204 HIV-1 protease ritonavir 1HXW   -13.63±0.07 -2.5 11.1 2005
205 HIV-1 protease lopinavir 1MUI 1HHP -14.24±0.12 2.8 17 2005
206 HIV-1 protease nelfinavir 1OHR 1HHP -12.51±0.1 3.6 16.1 2005
207 HIV-1 protease acetyl pepst 5HVP   -8.84±0.04 6.7 15.5 2005
208 HIV-1 protease Indinavir 2BPX   -12.58±0.1 2.1 14.7 2005
289 HIV-1 protease saquinavir   1HHP -13.07±0.05 2 15.1 2005
439 HIV-1 protease Tipranavir ( 2O4P 1HHP -14.6 -0.7 13.9 2007
440 HIV-1 protease Atazanavir ( 2O4K 1HHP -14.3 -4.2 10.1 2007
441 HIV-1 protease Lopinavir (L 2O4S 1HHP -14.3 -2.4 11.9 2007
183 HIV-1 protease m APV 1T7J   -11.7 -7 4.7 2004
184 HIV-1 protease m TMC114 1T7I   -13.7 -10 3.7 2004
442 HIV-1 protease M Tipranavir ( 2O4L   -12.5 -4.3 8.2 2007
443 HIV-1 TRM protea Tipranavir ( 2O4N   -10.6 -3.6 6.9 2007
199 HMG-CoA reductas fluvastain 1HWI   -9±0.4 0 9±0.4 2005
200 HMG-CoA reductas cerivastatin 1HWJ   -11.4±0.4 -3.3±0.2 8.1±0.4 -150 2005
201 HMG-CoA reductas atorvastatin 1HWK   -10.9±0.8 -4.3±0.1 6.6±0.6 -170 2005
202 HMG-CoA reductas rosuvastatin 1HWL   -12.3±0.7 -9.3±0.1 3±0.7 -460 2005
186 HSA (human serum halothane 1E7B 1E78 -3.55 -4.86±0.1 -1.31±0.02 2004
187 HSA (human serum propofol 1E7A 1E78 -4.47 -15.4±6.2 -15.6±4.3 2004
343 HSA (human serum desflurane   1E78 -4.786 -3.684±0.554 1.102±0.589 2004
344 HSA (human serum isoflurane   1E78 -4.433 -3.737±0.07 0.696±0.118 2004
345 HSA (human serum enflurane   1E78 -4.262 -5.267±0.08 -1.005±0.122 2004
346 HSA (human serum sevoflurane   1E78 -3.598 -1.699±0.675 1.899±1.104 2004
278 Human EphB4 Ephr YLFS-RAW 2BBA   -9.7±0.2 -13.8±0.5 -4.4±0.1 2006
221 human galectin-3 NacNAc 1KJL   -5.6 -9.6±0.6 -4 2005
279 human growth hor Magnesium   1HGU -5.95 -4.23 1.72 2006
256 Human peptidyl p peptide 1   1NMV -10.65±0.06 -6.3±0.02 5±0.09 2006
257 Human peptidyl p peptide 2   1NMV -8.58±0.07 -5±0.09 3.3±0.2 2006
403 human renin compound 7 2I4Q   -9.27 -8.9 0.37 2007
402 human renin compound 3 2IKU   -9.77 -10 -0.23 2007
401 human renin compound 1 2IKO   -7.5 -9.5 -2 2007
405 human renin compound 11 2IL2   -9.78 -9.35 0.43 2007
404 human renin compound 8 2G1S   -8.77 -6.8 1.97 2007
123 human stromelysi PD169469   1CQR -8.33±0.88 -11.5±0.2 -3.17±0.89 2000
124 human stromelysi PD166793   1CQR -9.62±0.13 -10.1±0.3 -0.48±0.33 2000
88 human thrombin inogatran 1K21 2AFQ -11.42 -13.81±0.48 -2.39 -631 2001
89 human thrombin melagatran 1K22 2AFQ -11.44 -8.84±0.29 2.6 -678 2001
323 human thrombin Napsagatran   2AFQ -9.63 -5.83±0.21 3.8 -599 2001
324 human thrombin CRC220   2AFQ -11.75 -11.58±0.24 0.17 -869 2001
438 hydrolytic antib transition-s 2DQT   -13.46 -9.31±0.05 4.15 2007
190 I-domain of LFA- inhibitor 1RD4 1LFA -10.73 -7.7 3.03 2004
248 I-FABP ANS (1 -Sulf   1AEL -6.9 -8.6 -1.8 1996
237 Iron(II) lipoxyg 4-nitrocatec 1NO3 1RRH -7.8±0.2 -6±1 5±4 1998
351 Iron(II) lipoxyg 3,4-dihydrox   1RRH -6.7±0.2 -10±2 -3.6±2.1 1998
348 ketopantoate red NADPH   1KS9 -8.89±0.03 -3.16±0.01 5.73±0.04 2005
347 ketopantoate red NADP+ 1YJQ 1KS9 -7.13±0.05 -3.15±0.06 3.97±0.08 2005
349 ketopantoate red ketopantoate   1KS9 -3.13±0.01 -5.6±0.1 -2.5±0.1 2005
350 ketopantoate red pantoate   1KS9 -4.91±0.02 -8.1±0.2 3.2±0.2 2005
407 ketopantoate red 2p-phospho-A 1YON 1KS9 -5.8±0.07 -3.01±0.31 2.79±0.41 2006
252 lactose permease TDG (thiodig 1PV7 1PV6 -6 -5.6 0.4 2006
390 Lck SH2 domain Lck Tyr(P)-5   1BHH -7.34 -8.38 -1.05 1995
229 Lck SH2 domain EPQ(pY)EEIPI 1LCJ 1BHH -9.58 -9.24 0.33 1998
377 Lck SH2 domain EPQ(pY)EEEPI   1BHH -9.1 -7.81 1.29 1998
378 Lck SH2 domain EPQ(pY)EEVPI   1BHH -9.27 -6.83 2.44 1998
255 LTB4 12HD/PGR indomethacin 2DM6 1V3T -5.4 -20.2±2.28 -14.8 2006
219 lumazine synthas TS-44 1W19   -7.82±0.08 -12.72±0.6 -4.9 2005
220 lumazine synthas TS-70 1W29   -7.69±0.02 -13.83±0.39 -6.14 2005
447 lumazine synthas GJ43   2JFB -8.63±0.02 -8.97±0.05 -0.35±0.003 2007
1 luminase synthas JC33 2C97   -8.52±0.05 -10.52±0.11 -2 2006
258 luminase synthas TS13 2C9B   -7.68±0.04 -12.87±0.22 -5.19±0.003 2006
259 luminase synthas TS50 2C92   -7.88±0.11 -15.14±0.55 -7.27±0.006 2006
260 luminase synthas TS51 2C94   -9.45±0.07 -9.83±0.09 -0.38±0.003 2006
261 luminase synthas TS68 2C9D   -8.76±0.07 -8.46±0.12 0.29±0.003 2006
411 MMP-12 AHA 1Y93 1OS9 -3.01 -3.18 -0.17 2007
412 MMP-12 compound 1   1OS9 -9.83 -9.09 0.74 2007
413 MMP-12 compound 2   1OS9 -9.8 -6.77 3.03 2007
414 MMP-12 compound 3   1OS9 -10.5 -8.52 1.98 2007
415 MMP-12 compound 4   1OS9 -11.76 -8.85 2.91 2007
416 MMP-12 compound 5   1OS9 -10.09 -6.46 3.63 2007
417 MMP-12 compound 6   1OS9 -11.05 -9.65 1.4 2007
418 MMP-12 compound 8   1OS9 -11.22 -8.39 2.83 2007
419 MMP-12 compound 9   1OS9 -10.86 -8.12 2.74 2007
420 MMP-12 compound 12 1Z3J 1OS9 -11.42 -8.24 3.18 2007
421 MMP-12 compound 13   1OS9 -11.05 -8.89 2.16 2007
422 MMP-12 compound 14   1OS9 -11.12 -8.08 3.04 2007
423 MMP-12 galardin   1OS9 -11.05 -4.07 6.98 2007
424 MMP-12 actinonin   1OS9 -9.53 2.2 11.73 2007
191 MUP-1 (major uri IBMP 1QY1 1QY0 -8.1±0.07 -10.64±0.1 -2.54±0.12 2004
192 MUP-1 (major uri IPMP 1QY2 1QY0 -9.2±0.03 -11.44±0.21 -2.24±0.21 2004
408 MUP-1 (major uri nonanol 1ZNK 1QY0 -9.27±0.05 -15.19±0.1 -5.92±0.12 2006
409 MUP-1 (major uri octanol 1ZNH 1QY0 -8.5±0.02 -13.85±0.14 -5.35±0.14 2006
209 MUP-1 mutant (Y1 2-isobutyl-3 1YP6 1YP7 -8.43±0.02 -7.51±0.19 0.92±0.19 2005
66 MUP-I (mouse maj SBT (2-sec-b 1I06 1I04 -8.38±0.52 -11.2±0.34 -2.78±0.14 -165 2003
67 MUP-I (mouse maj IBT (isobuty   1I04 -9.04±0.45 -11.9±0.34 -2.87±0.14 -56 2003
68 MUP-I (mouse maj PT (2-n-prop   1I04 -8.16±0.41 -10.7±0.32 -2.6±0.13 -53 2003
69 MUP-I (mouse maj IPT (2-isopr   1I04 -7.79±0.39 -10.8±0.32 -3.04±0.15 -111 2003
70 MUP-I (mouse maj ET (2-ethyl-   1I04 -6.93±0.35 -10±0.33 -3.1±0.16 -45 2003
71 MUP-I (mouse maj MT (2-methyl   1I04 -5.61±0.28 -9.7±0.32 -4.18±0.21 -134 2003
90 MurA UDPNAG 1UAE 1NAW -6 6.88 12.87 2001
216 murine ferrochel mesoporphyri 1C1H 1DOZ -7.21 -23.19 -15.98 2005
78 MutT 8-oxo-dGMP 1PUN 1MUT -9.8±0.2 -39±0.7 -29.2±0.7 2002
93 NDP kinase 3p-deoxyADP 1HIY 2NCK -4.72 -2.4 2.3 2001
353 NDP kinase GDP   2NCK -5.74 -5.5 0.3 2001
354 NDP kinase IDP   2NCK -5.35 -3 2.4 2001
355 NDP kinase Mg-ADP   2NCK -5.8 -2.5 3.3 2001
356 NDP kinase 2p-deoxyADP   2NCK -4.95 -2.6 2.4 2001
357 NDP kinase 3p-NH2ADP   2NCK -4.13 -0.6 3.5 2001
358 NDP kinase AMP-PNP   2NCK -4.86 -0.6 4.3 2001
359 NDP kinase TDP   2NCK -4.68±0.1 -3.2±0.2 1.5±0.3 2001
360 NDP kinase UDP   2NCK -4.38 -1.7 2.7 2001
361 NDP kinase CDP   2NCK -3.93 -1 2.9 2001
362 NDP kinase AZTDP   2NCK -4.08 -3.3 0.8 2001
432 NDP kinase ADP   2NCK -5.72±0.1 -4.2±0.6 1.1±0.6 2001
148 OppA KAK 1JET 1RKM -9.82 4.8±0.48 14.59±0.21 1999
149 OppA KCK 1B05 1RKM -9.7 1.89±0.31 11.51±0.33 1999
150 OppA KDK 1B4Z 1RKM -7.12 1.93±0.31 9±0.19 1999
151 OppA KEK 1JEU 1RKM -9.29 2.7±0.21 11.94±0.26 1999
152 OppA KFK 1B40 1RKM -9.91 5.25±0.38 15.1±0.38 1999
153 OppA KGK 1B3L 1RKM -8.03 3.37±0.09 11.35±0.19 1999
154 OppA KHK 1B3F 1RKM -9.39 4.92±0.72 14.28±0.93 1999
155 OppA KIK 1B3G 1RKM -9.15 4.9±0.91 14±1.05 1999
156 OppA KKK 2OLB 1RKM -7.55 9.41±0.21 16.91±0.19 1999
157 OppA KLK 1B9J 1RKM -8.1 5.88±0.21 13.92±0.74 1999
158 OppA KMK 1B32 1RKM -9.67 3.49±0.19 13.11±0.29 1999
159 OppA KNK 1B5I 1RKM -9.6 1.84±0.05 11.44±0.26 1999
160 OppA KPK 1B46 1RKM -7.19 3.96±0.14 11.11±0.1 1999
161 OppA KQK 1B5J 1RKM -10.13 2.72±0.12 12.75±0.12 1999
162 OppA KRK 1QKA 1RKM -8.07 8.6±1.74 16.65±1.98 1999
163 OppA KSK 1B51 1RKM -10.03 2.13±0.17 12.09±0.14 1999
164 OppA KTK 1B52 1RKM -9.7 4.13±0.41 13.76±0.36 1999
165 OppA KVK 1QKB 1RKM -10.01 5.35±0.1 15.36±0.31 1999
166 OppA KWK 1JEV 1RKM -9.36 7±0.24 16.29±0.24 1999
167 OppA KYK 1B58 1RKM -8.96 4.94±0.93 13.83±1 1999
168 OppA KNapK 1B0H 1RKM -9.12±0.05 4.97±0.12 14.09±0.24 1999
169 OppA KHphK 1B1H 1RKM -9.63±0.24 1.72±0.02 11.32±1.43 1999
170 OppA KOrnK 1B2H 1RKM -6.19±0.1 16.58±1.36 22.78±4.3 1999
171 OppA KChxK 1B3H 1RKM -8.46±0.07 4.87±0.17 13.52±1.91 1999
172 OppA KDabK 1B4H 1RKM -7.43±0.1 10.6±0.48 18.01±1.91 1999
173 OppA KDapK 1B5H 1RKM -8.19±0.02 10.68±0.79 18.86±2.63 1999
174 OppA KNvaK 1B6H 1RKM -10.68±0.17 1.89±0.45 12.53±1.91 1999
175 OppA KNleK 1B7H 1RKM -11.01±0.29 4.68±0.67 15.66±1.91 1999
11 osteoclast farne risedronate/ 1YV5 2F7M -8.8 1.8±0.4 10.5 2006
363 osteoclast farne risedronate   2F7M -7 3.9±0.2 10.9 2006
364 osteoclast farne zoledronate/   2F7M -10 2.1±0.03 12.1 2006
365 osteoclast farne isopentenyl   2F7M -7.1 -13.7±1.3 -6.6 2006
366 osteoclast farne isopentenyl   2F7M -6.3 13.4±1.3 19.7 2006
43 P450 2B4 bifonazole 2BDM 1SUO -7.5 -17.6 -10 2006
210 peanut lectin lactose 2PEL 1CQ9 -4.7±0.03 -9.7±0.3 -5±0.3 2005
238 PnrA inosine 2FQW   -8.95±0.05 -10.3±0.04 -1.38±0.41 2006
239 PnrA guanosine 2FQX   -9.58±0.04 -12.6±0.03 -3.05±0.29 2006
240 PnrA adenosine 2FQY   -8.81±0.09 -12.9±0.02 -4.07±0.21 2006
146 pOBP IBMP (2-isob 1DZK   -9.2 -23.22 -14.02 1999
433 PPA (porcine pan PAMI (peptid   1PIF -7.11±0.02 -10.2±0.2 -3.7±0.2 2005
406 PPIase Pin1 peptide   1PIN -10.74 -6.3±0.1 4.1±0.1 2006
120 PTP1B peptide   2HNP -9±0.1 -3.9±0.2 5.1±0.2 2000
121 PTP1B peptide   2HNP -7.9±0.2 -5.9±0.4 2±0.4 2000
122 PTP1B peptide   2HNP -7.8±0.07 -4.3±0.1 3.5±0.1 2000
198 R67 DHFR (dihydr NADPH 1   1VIE -7.71±0.05 -8.6±0.2 -0.89 2005
367 R67 DHFR (dihydr NADPH 2   1VIE -5.53±0.02 -5.8±2.5 -0.27 2005
368 R67 DHFR (dihydr NHDPH 1   1VIE -7.85±0.11 -6.7±0.11 1.15 2005
369 R67 DHFR (dihydr NHDPH 2   1VIE -5.97±0.06 -4.2±0.15 1.77 2005
370 R67 DHFR (dihydr thio-NADPH 1   1VIE -7.07±0.03 -6.9±0.04 0.18 2005
371 R67 DHFR (dihydr thio-NADPH 2   1VIE -5.66±0.02 -6.7±0.1 -1.04 2005
372 R67 DHFR (dihydr NADH   1VIE -6.15±0.01 -11±0.1 -4.85 2005
373 R67 DHFR (dihydr AcPADPH   1VIE -5.62±0.03 -2.4±0.08 3.22 2005
374 R67 DHFR (dihydr ATP-ribose   1VIE -5.23±0.02 -1.7±0.05 3.53 2005
375 R67 DHFR (dihydr ADP-ribose   1VIE -4.89±0.05 -1±0.06 3.89 2005
376 R67 DHFR (dihydr 2p,5p-diphos   1VIE -4.42±0.08 0.56±0.18 4.98 2005
217 Rho bicyclomycin 1XPO   -6.01±0.08 -0.79±0.72 5.22±0.8 2005
218 Rho SC- bicyclom 1XPU   -7.12±0.02 -1.34±0.62 5.78±0.26 2005
230 Ricinus communis galactose 1RZO   -4.3±0.02 -5.76±0.33 -1.43±0.38 1998
425 sirtuin p53-K382ac 2H2D 2H2I -7.36±0.07 -5.02±0.101 2.3 2006
426 sirtuin H3-K115ac 2H2G 2H2I -6.87±0.09 -5.91±0.7 0.961 2006
427 sirtuin H4-K79ac 2H2H 2H2I -6.79±0.08 -7.9±1.4 -1.11 2006
428 sirtuin H4-K77ac   2H2I -6.65±0.07 -9.54±2.01 -2.88 2006
429 sirtuin H4-K16ac   2H2I -8.1±0.03 -23±1.77 -14.9 2006
430 sirtuin H4-K77ac(A76   2H2I -7.37±0.08 -7.43±0.47 -0.052 2006
431 sirtuin H4-K77ac(K78   2H2I -6.54±0.06 -2.7±0.116 3.85 2006
224 SjGST Y7F mutant S-octyl-GSH 1U88   -7.76±0.02 -7.26±0.19 0.51±0.06 -177 2005
389 Src SH2 domain hmT Tyr(P)-3   1SPR -8.56 -8.44 0.12 1995
91 Src SH2 Domain Ac-pYEEIE-NH 1HCS 1SPR -10.08 -6.81 3.27 1997
48 Src SH2 domain 1,2,3-trisub 1IS0 1SPR -9.55±0.07 -5.91±0.04 5.07±0.3 -213 2002
379 Src SH2 domain compound 3   1SPR -9.01±0.01 -6.06±0.05 2.95±0.06 2002
380 Src SH2 domain compound 6   1SPR -9.8±0.2 -7.33±0.03 2.47±0.15 -213 2002
381 Src SH2 domain compound 5   1SPR -9.26±0.06 -5.01±0.05 4.26±0.12 2002
382 Src SH2 domain compound 7   1SPR -9.72±0.06 -6.92±0.09 2.8±0.06 2002
249 streptavidin strep-tag 1RST 1SWB -6.071 -12.559±0.087 -6.489 1996
250 streptavidin H2N-CWHPQAGC   1SWB -6.71 -13.85±0.11 -7.14 1996
235 streptavidin biotin 1MK5 1SWB -18 -24.9±0.4 -6.6±0.4 -345 1998
147 stromelysin-1 PD166793   1CQR -9.62±0.13 -10.1±0.3 -0.43±0.33 -66.1 1999
383 stromelysin-1 PD180557   1CQR -10.1±0.1 -17.4±0.8 -7.34±0.77 -106 1999
384 stromelysin-1 galardin   1CQR -11.6±0.2 -8.82±0.52 2.34±0.54 -118 1999
49 SurA heptameric p   1M5Y -7.44 -19.41±0.06 -11.97 2003
455 Test    
225 Tet repressor tetracycline 2TRT   -9.58±0.07 -12.3±0.49 -2.77±0.49 2005
292 thymidine kinase thymidine 1E2J 1E2H -7.2±0.35 -19.1±0.98 -11.9±1.5 -360 2000
293 thymidine kinase ATP   1E2J -9±0.35 -13.8±0.69 -4.8±1.5 -140 2000
386 TmGH1 tetrahydroox   1OD0 -6.87±0.06 -7.93±0.22 -0.94±0.24 2004
385 TmGH1 tetrahydroox 1W3J 1OD0 -8.61±0.04 -11.15±0.04 -2.52±0.08 2004
387 TmGH1 tetrahydroox   1OD0 -9.77±0.01 -6.81±0.11 3.09±0.11 2004
99 trypsin p-benzamidin   1S0Q -5.71 -2.94 2.77 -54.93 2001
98 trypsin p-benzamidin   1S0Q -6.04 -3.75 2.29 -100.32 2001
97 trypsin p-benzamidin   1S0Q -6.95 -6.42 0.53 -124.2 2001
56 trypsin benzamidiniu 1S0R 1S0Q -6.35±0.07 -4.51±0.1 1.84±0.14 -400 2003
57 trypsin p-methylbenz   1S0Q -6.59±0.02 -4.42±0.07 2.17±0.05 -420 2003
58 trypsin p-ethylbenza   1S0Q -6.07±0.05 -3.32±0.14 2.75±0.17 -693 2003
59 trypsin p-(n-propyl)   1S0Q -6.14±0.05 -3.03±0.12 3.1±0.14 -598 2003
60 trypsin p-(i-propyl)   1S0Q -5.42±0.05 -1.67±0.1 3.82±0.12 -419 2003
61 trypsin p-(n-butyl)-   1S0Q -6.26±0.05 -2.36±0.12 3.89±0.17 -728 2003
62 trypsin p-(n-pentyl)   1S0Q -6.5±0.02 -2.36±0.1 4.13±0.07 -632 2003
63 trypsin p-(n-hexyl)-   1S0Q -6.97±0.02 -2.53±0.05 4.44±0.07 -849 2003
64 trypsin p-(n-hexyl)-   1S0Q -6.97±0.02 -2.53±0.05 4.44±0.07 -849 2003
236 tryptophan repre tryptophan 1WRS 1WRT -6.29±0.05 -12.24±0.44 -5.95±0.49 1996
450 tryptophanyl-tRN adenosine-5 2OV4   -6.56 0.85 7.45 2007
448 TtgABC repressor phloretin 2UXI   -10.2±0.1 -15.1±0.1 -4.9±0.2 2007
449 TtgABC repressor naringenin 2UXU   -6.6±0.1 -10.8±0.1 -4.2±0.1 2007
188 TtPNP (Thermus t adenosine 1ODI 1ODK -5.74 -23 -17.3 2004
189 TtPNP (Thermus t guanosine 1ODJ 1ODK -5.59 -23.7 -18.1 2004
392 vancomycin N-acetyl-gly   1AA5 -3.1 -8.36 -5.3 1993
393 vancomycin N-acetyl-D-a   1AA5 -3.37 -8.55 -5.23 1993
394 vancomycin N-ac-D-ala-D   1AA5 -5.21 -8.5 -3.3 1993
395 vancomycin N-ac-gly-D-a   1AA5 -5.11 -8.5 -3.44 1993
396 vancomycin N,N-diacetyl   1AA5 -7.79 -12.73 -4.94 1993
397 vancomycin N-fumaryl-D-   1AA5 -4.73 -10.49 -5.8 1993
398 vancomycin N-succinyl-D   1AA5 -4.23 -10.25 -6.09 1993
399 vancomycin acetate 1AA5   -1.1 -5.73 -4.66 1993
400 vancomycin diacetyl-L-l   1AA5 -3.8 -3.7 0.1 1999
54 VHS domain of GG memapsin 2 ( 1PY1 1JWF -5.99 -10.9±1.3 -4.91 2003
253 Vr CSBP (Vigna r zeatin 2FLH   -5.323±0.06 -3.27 2.04 2006
254 Vr CSBP (Vigna r zeatin H+ 2FLH   -5.7±0.07 -1.36 4.34 2006
40 WGA3 (2 site mod GlcNacBeta1, 1K7T   -5.2±0.21 -23.9±1 -18.7±0.75 2002
42 WGA3 (2 site mod GlcNAcbeta1, 1K7U   -5.1±0.2 -24.1±0.96 -19±0.76 2002
41 WGA3 (4 site mod GlcNAcbeta1, 1K7U   -5.3±0.37 -11.4±0.8 -6.1±0.43 2002
39 WGA3(4 site mode GlcNacBeta1, 1K7T   -5.4±0.38 -11.1±0.78 -5.7±0.4 2002

User Submitted

ID Receptor Name Ligand Name Ligand
Structure		 PDB
(complex)		 PDB
(receptor)		 ΔG
(kcal/mol)		 ΔH
(kcal/mol)		 TΔS
(kcal/mol)		 ΔCp
(cal/molT)		 Pub. Date
461      
544 Abisfaniats Abisfaniats      
531 absopep absopep      
489 accege accege      
468 Acouccalo Acouccalo      
532 addesiaUnfank addesiaUnfan      
466 Addighkayag Addighkayag      
498 Aduncdupunows Aduncdupunow      
477 Aftecitiems Aftecitiems      
570 Aliet Aliet      
493 alomeob alomeob      
516 alomeob alomeob      
534 alomeob alomeob      
556 alomeob alomeob      
563 alomeob alomeob      
553 Amotomabmag Amotomabmag      
587 anattarve anattarve      
499 Apaccepay Apaccepay      
572 Appef Appef      
585 Appefrey Appefrey      
502 Beidswapwes Beidswapwes      
526 Beislippize Beislippize      
552 Biansilkiny Biansilkiny      
488 bodybuilding-sup bodybuilding      
575 Brariaamudged Brariaamudge      
582 BumJexGuepe BumJexGuepe      
540 bvzceck755 bvzceck755      
490 BydayViar BydayViar      
543 Canygieflenna Canygieflenn      
539 Cetrodadieree Cetrodadiere      
568 Choippido Choippido      
508 CHOTTOKYPOT CHOTTOKYPOT      
549 Ciskishonee Ciskishonee      
561 Ciskishonee Ciskishonee      
524 ClettyDat ClettyDat      
479 Clornolve Clornolve      
548 conunjups conunjups      
581 Dyedperie Dyedperie      
467 eageffiltef eageffiltef      
465 ebadzhigurdas ebadzhigurda      
511 ebadzhigurdas ebadzhigurda      
503 Ediberferse Ediberferse      
483 EmairmTottarm EmairmTottar      
463 Emodiadum Emodiadum      
579 empimaral empimaral      
580 Enathhoth Enathhoth      
546 Engittettat Engittettat      
513 ensuexyHaxy ensuexyHaxy      
517 extickexhilky extickexhilk      
586 Fedegreme Fedegreme      
462 FemoDoox FemoDoox      
470 FemoDoox FemoDoox      
504 FemoDoox FemoDoox      
522 FemoDoox FemoDoox      
554 FemoDoox FemoDoox      
573 FemoDoox FemoDoox      
578 fluereweeks fluereweeks      
486 gifeflief gifeflief      
507 glitterge glitterge      
509 glitterge glitterge      
519 glitterge glitterge      
525 glitterge glitterge      
536 glitterge glitterge      
542 glitterge glitterge      
547 glitterge glitterge      
559 Glutlefette Glutlefette      
571 Grile Grile      
514 Haibiaziz Haibiaziz      
480 HewPierntribe HewPierntrib      
471 HoasturaLaums HoasturaLaum      
474 iodizerne iodizerne      
583 JarJectenhase JarJectenhas      
484 jemetague jemetague      
584 kekAcevekic kekAcevekic      
478 kneedyduLakes kneedyduLake      
512 lofgroody lofgroody      
555 lofgroody lofgroody      
491 LouriSiziroro LouriSiziror      
518 LouriSiziroro LouriSiziror      
551 lrjcyhf950 lrjcyhf950      
528 neopayVap neopayVap      
560 Obecerimb Obecerimb      
473 popazermusht popazermusht      
506 popazermusht popazermusht      
533 popazermusht popazermusht      
550 popazermusht popazermusht      
492 preerboacen preerboacen      
588 QuemBodotut QuemBodotut      
494 ReoroWeerypaw ReoroWeerypa      
569 roanD roanD      
574 roanD roanD      
496 ropyJoivy ropyJoivy      
545 Sanfranc Sanfranc      
565 scurrectita scurrectita      
485 Seakdarbela Seakdarbela      
510 Shalgaxarly Shalgaxarly      
523 snanieksmooms snanieksmoom      
564 Sobsteere Sobsteere      
472 speeskMudge speeskMudge      
481 spisistduelty spisistduelt      
469 stispusereild stispusereil      
521 StowlySpously StowlySpousl      
577 Teaxreseforry Teaxreseforr      
535 Teessylitle Teessylitle      
497 Teraacide Teraacide      
576 tetnshm316 tetnshm316      
537 Tormamox Tormamox      
557 Tormamox Tormamox      
566 Tormamox Tormamox      
475 TothGlyhots TothGlyhots      
515 uggs boots uggs boots      
495 Unsessyarralk Unsessyarral      
505 Unsessyarralk Unsessyarral      
527 UttertElalF UttertElalF      
476 UttetlyClacle UttetlyClacl      
482 UttetlyClacle UttetlyClacl      
500 Vageseeaniaps Vageseeaniap      
538 VetteMade VetteMade      
558 ViagraPharmac ViagraPharma      
541 ViagraPharmaci ViagraPharma      
562 ViagraPharmaqo ViagraPharma      
487 Vitlypypepype Vitlypypepyp      
520 Wazycreetty Wazycreetty      
530 whivaHiccap whivaHiccap      
567 WhoroNinivova WhoroNinivov      
464 work-from-home work-from-ho      
501 Wretilunlicle Wretilunlicl      
529 Wretilunlicle Wretilunlicl      

OK User Submitted Data?

 
410 West 10th Street, Suite 5000 Indianapolis, IN 46202-5122 Phone: 317.278.9650 Fax: 317.278.9217
9 2 8 1 7